|
![]() |
|||
|
||||
OverviewFull Product DetailsAuthor: Josep Bassaganya-RieraPublisher: Springer Nature Switzerland AG Imprint: Springer Nature Switzerland AG Edition: Softcover reprint of the original 1st ed. 2018 Dimensions: Width: 15.50cm , Height: 0.50cm , Length: 23.50cm Weight: 0.454kg ISBN: 9783030103392ISBN 10: 3030103390 Pages: 82 Publication Date: 12 January 2019 Audience: Professional and scholarly , Professional & Vocational Format: Paperback Publisher's Status: Active Availability: Manufactured on demand ![]() We will order this item for you from a manufactured on demand supplier. Table of ContentsChapter 1: Introduction to Accelerated Path to Cures and Precision Medicine in Inflammatory Bowel Disease.- Chapter 2: Computer-Aided Drug Discovery.- Chapter 3: Preclinical Studies: Efficacy and Safety.- Chapter 4: From Nutritional Immunology to Drug Development.- Chapter 5: Development of Synthetic Patient Populations and In Silico Clinical Trials.ReviewsAuthor InformationDr. Josep Bassaganya-Riera is a serial entrepreneur and innovator who has served as the Director of the Nutritional Immunology and Molecular Medicine Laboratory (NIMML) at the Biocomplexity Institute of Virginia Tech since 2002. The NIMML tackles unsolved challenges in complex human diseases with unmet clinical needs. His research has received over $55 million in competitive R&D funding to combine advanced computational technologies with preclinical and clinical experimentation. The NIMML translates novel scientific discoveries into commercial applications that address unmet patient or consumer needs. Dr. Bassaganya-Riera has published over 150 peer-reviewed publications in reputable biomedical journals, founded 3 successful biotech companies (Pervida, Biotherapeutics and Landos Biopharma), and was recently named 2017 Innovator of the Year by the Roanoke-Blacksburg Technology Council. Dr. Bassaganya-Riera, and his companies have been active members of a statewide group that supports the planning behind the Governor’s 2015 Virginia Bioscience Initiative. This initiative calls for Virginia to be in the top three pharmaceutical regions by 2023. Dr. Bassaganya-Riera was a featured presenter at the Governor’s Forum on Bio and Big Data. Tab Content 6Author Website:Countries AvailableAll regions |